← All organizations
Highest phase reached
Phase 2
First clinical trial
Oct 1, 2021Last known activity
Nov 1, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 4 trials)
Phase 2 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Recent trials (10)
- NCT05583045Overall official - principal investigatorN/ANov 1, 2022
- NCT05583045Sponsor investigatorN/ANov 1, 2022
- NCT05583045OfficialN/ANov 1, 2022
- NCT05583045Reponsible party - principal investigatorN/ANov 1, 2022
- NCT05583045Lead sponsorN/ANov 1, 2022
- NCT05657093CollaboratorN/AApr 30, 2022
- NCT05397509Reponsible party - principal investigatorN/AApr 29, 2022
- NCT05397509Overall official - principal investigatorN/AApr 29, 2022
- NCT05397509Lead sponsorN/AApr 29, 2022
- NCT05054075CollaboratorPhase 2Oct 1, 2021
Details
- Last known activity
- Nov 1, 2022